🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

Great study Maria Papathanasiou Дарья Опокина My practice is to stop PDE5i when VAD patients are stable (if PVR <3), approx 1/4 feel worse, so I restart- this is a very helpful study suggesting no harm and possible benefit to weaning off pubmed.ncbi.nlm.nih.gov/37056058/

From a consult I saw a while ago Check Check Ch- wait a minute…

Our third year cardiology fellows Dr. Ali Azeem and Dr. Rafey Feroze represented UH/Case at ACC, and congrats to Dr. Feroze for competing for the Young Investigator award!

Anyone having good results with vericiguat/Verquvo ? have started it about 10 times- 50% of patients feel the same and request to stop due to⬆️⬆️ pill cost, 50% feel much worse, 0⃣ patients currently on, feels different than early ARNI/SGLT2i era #heartfailure #cardstwitter

Women in UH Harrington Heart & Vascular Institute with artistic talents out in full force tonight. I love this multi- talented group Judith Mackall Saneka Chakravarty ellen sabik @JunLiMD Karem Harth, MD MHS @DrMoniqueR Mehdi Shishehbor, DO Madonna Michael, MD

Please welcome the class of 2027 Cardiovascular Disease fellows! They just crushed their first week of fellowship 💪🏼 Wishing them all the best throughout their time here at UH. #CardiovascularDisease #Fellowship #UH #Classof2027 🎓

My ⁦⁦UH Harrington Heart & Vascular Institute⁩ partners ⁦@JunLiMD⁩ ⁦Yulanka Castro, M.D.⁩ doing a live case from Cleveland ⁦CV Innovations⁩ #CVI2024 today. proud to work with these 2 rockstar endovascular specialists who happen to be women #WIC too. ⁦⁦Women As One⁩ ⁦Mehdi Shishehbor, DO⁩

Congratulations to Yulanka Castro, M.D., selected by the SCAI Board and Membership & Credentialing Committee as one of their 2024’s 30 in Their 30’s award winners! This award honors early-career physicians poised to become future leaders in interventional cardiology.

Great talk to end to the day! UH Harrington Heart & Vascular Institute

Great job by our HF fellow alum Vince Salvador presenting on fall screening and outcomes after VAD/Tx at #AHA2024 UH Harrington Heart & Vascular Institute UH Case Western Cardiology Fellows

One of the challenges of integrating finerenone is that FINEARTS-HF don’t look like my typical HFpEF patients (probnp>1000, high BB use, very low SGLT2i) but trial should be commended for 50% women- no apparent sex specific effects #AHA2024

Most biomarkers should not be the targets of therapy, and I would be very careful using CRP clinically at the individual patient level pmc.ncbi.nlm.nih.gov/articles/PMC31….

Great job by Team Ohio (including one of UH Case Western Cardiology Fellows chief fellows Ghassan Daher) who crushed the HF category but sustained a narrow loss to Team Missouri in fellow jeopardy. No comment on possible buzzer shenanigans 😉🤐 #Acc2025 American College of Cardiology UH Harrington Heart & Vascular Institute

🆕 Clinical Transplantation: Falls assessment may identify patients at risk for worse clinical outcomes after LVAD or ❤️ transplant. dx.doi.org/10.1111/ctr.70… #Frailty #HeartFailure TJ O’Neill Eiran Gorodeski, MD, MPH

Great Job by our star first year fellow Pranati Sreepathy presenting at the Ohio Chapter-ACC Spring Summit (appropriately discussing the SUMMIT Trial) a bonus during a great conference! UH Case Western Cardiology Fellows UH Harrington Heart & Vascular Institute ellen sabik